Blogs

Blog post list

• Health inequalities - an update to NICE’s methods for health technology evaluation

  Our new modular update focuses on how we consider health inequalities when evaluating technologies for use in the NHS, and how you can get involved in suggesting future updates.

• HST routing criteria: encouraging innovation in the treatment of ultra-rare diseases

  Our chief medical officer, Professor Jonathan Benger, explains the crucial role the HST programme plays in encouraging innovation in the treatment of ultra-rare diseases. He also highlights why effective routing is essential to getting the best care to patients across the NHS.

• Harnessing expertise to improve patient access to innovative health technologies

  Introducing the Medicines and Medical Devices Access Initiative (MMD): a new collaboration that aims to improve patient access to safe, clinically and cost-effective healthcare products.

• NICE’s prioritisation process explained – what healthtech developers need to know

  Understand why we're prioritising key topic areas for evaluation and what it means for innovators

• Should NICE’s cost-effectiveness thresholds change?

  We explore the ongoing debate around NICE’s cost-effectiveness thresholds and what the future holds.